ITO Lab. – Cell Fate Dynamics and Therapeutics –

PUBLICATIONS

• Cancer progression by reprogrammed BCAA metabolism in myeloid leukemia.

  Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, Tayyari F, McSkimming D, Kannan N, Tojo A, Edison A, Ito T.  
  Nature 545:500-504 (2017).

• Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia.

  Zimdahl B#, Ito T#, Blevins A, Bajaj J, Konuma T, Weeks J, Koechlein CS, Kwon HY, Arami O, Rizzieri D, Broome HE, Chuah C, Oehler VG, Sasik R, Hardiman G, Reya T.
  Nat Genet 46:245-52 (2014).

• Regulation of myeloid leukaemia by the cell fate determinant Musashi.

  Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L, Goldman J, Goh H, Kim SH, Kim DW, Chuah C, Oehler VG, Radich JP, Jordan CT, Reya T.
  Nature 466:765-8 (2010)